Enterprise Value
$226.17 M
-$29.42 M-11.51%
9 min ago
Summary
- As of February 7, 2025, SGMO enterprise value is $226.17 million, with a fall of -$29.42 million (-11.51%) during the most recent trading day.
- Over the past year, SGMO enterprise value has increased by +$142.28 million (+169.61%).
- SGMO enterprise value is now -90.38% below its all-time high of $2.35 billion.
Performance
SGMO Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
SGMO Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -11.5% | -11.0% | -11.0% |
| 1 m1 month | -19.4% | -18.6% | -18.6% |
| 3 m3 months | -60.9% | -59.8% | -59.8% |
| 6 m6 months | +26.9% | +34.3% | +34.0% |
| ytdytd | +12.3% | +11.7% | +11.7% |
| 1 y1 year | +169.6% | +161.2% | +123.0% |
| 5 y5 years | -73.0% | -72.8% | -84.9% |
SGMO Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -19.4% | $206 M | +10.1% | |
| 3 m | 3-month | $614 M | -63.2% | $182 M | +24.3% |
| 6 m | 6-month | $614 M | -63.2% | $152 M | +49.1% |
| 1 y | 1-year | $614 M | -63.2% | $55 M | +309.3% |
| 3 y | 3-year | $924 M | -75.5% | $35 M | +542.3% |
| 5 y | 5-year | $2.35 B | -90.4% | $35 M | +542.3% |
| alltime | all time | $2.35 B | -90.4% | $7.70 M | +2837.0% |
Sangamo Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $226.17 M(+12.3%) |
| 2024 | $201.35 M(+113.2%) |
| 2023 | $94.44 M(-80.2%) |
| 2022 | $476.40 M(-50.6%) |
| 2021 | $963.62 M(-54.7%) |
| 2020 | $2.13 B(+127.7%) |
| 2019 | $934.67 M(-11.9%) |
| 2018 | $1.06 B(-23.1%) |
| 2017 | $1.38 B(+596.2%) |
| 2016 | $198.04 M(-65.4%) |
| 2015 | $572.86 M(-45.2%) |
| 2014 | $1.04 B(+22.2%) |
| 2013 | $854.38 M(+187.5%) |
| Date | Value |
|---|---|
| 2012 | $297.20 M(+124.3%) |
| 2011 | $132.49 M(-54.4%) |
| 2010 | $290.52 M(+18.5%) |
| 2009 | $245.21 M(+99.0%) |
| 2008 | $123.20 M(-76.0%) |
| 2007 | $512.63 M(+134.5%) |
| 2006 | $218.60 M(+108.8%) |
| 2005 | $104.69 M(-26.8%) |
| 2004 | $143.00 M(+12.9%) |
| 2003 | $126.70 M(+122.9%) |
| 2002 | $56.83 M(-74.3%) |
| 2001 | $221.30 M(-47.5%) |
| 2000 | $421.72 M |
FAQ
- What is Sangamo Therapeutics enterprise value?
- What is the all time high enterprise value for Sangamo Therapeutics?
- What is SGMO enterprise value year-to-date change?
- What is Sangamo Therapeutics enterprise value year-on-year change?
What is Sangamo Therapeutics enterprise value?
The current enterprise value of SGMO is $226.17 M
What is the all time high enterprise value for Sangamo Therapeutics?
Sangamo Therapeutics all-time high enterprise value is $2.35 B
What is SGMO enterprise value year-to-date change?
Sangamo Therapeutics enterprise value has changed by +$24.83 M (+12.33%) since the beginning of the year
What is Sangamo Therapeutics enterprise value year-on-year change?
Over the past year, SGMO enterprise value has changed by +$142.28 M (+169.61%)